- authorisedTherapeutic exploratory (Phase II)
An open-label, phase 2 pilot study on the efficacy and safety of Piclidenoson in patients with Lowe syndrome
This Phase 2 clinical trial is testing a medicine called Piclidenoson for adult men with Lowe syndrome. Researchers want to see if the drug can safely improve kidney function over six months. In this study, every participant receives the real medicine, with no dummy pills or placebos used.
Italy - recruiting
National Registry of Rare Kidney Diseases
This registry is collecting information from people with rare kidney diseases across the UK. It aims to improve understanding, create better care guidelines, and help develop new treatments for these conditions. If you have a rare kidney disease, your information could help.
United Kingdom